With the introduction of this glucagon-like peptide-1 receptor agonist (GLP-1 RA), efpeglenatide, could we see new cardiovascular and renal benefits for patients with type 2 diabetes?

Major electrocardiogram abnormalities have been found in patients with type 2 diabetes. 

How does basal insulin compare to other diabetes medications in its impact on cholesterol and triglycerides?

Male, 72 years of age, type 2, insulin-requiring diabetes, also taking SGLT-2. Annual physical. No urinary complaints during the visit. Received annual lab work end of the workday, glucose elevated much higher than the reports. WBC elevated, 1200, no urine culture, but U/A did show cloudy....

Genetic risk scores can help provide insight into the problem of increasing youth-onset type 2 diabetes rates.

Analysis finds that for every increase of a BMI unit, there was a 5-15% excess risk of developing severe COVID-19. 

Study finds type 1 diabetes may account for 8% of diabetes cases in young adults.

American Diabetes Association symposium presents new phase 3 clinical trials of SURPASS-3 and SURPASS-5. 

Researchers assess the safety of intranasal insulin as a treatment for type 2 diabetes-associated cognitive impairment in aging adult populations. 

The internet has many different opinions of what an optimal diet is for athletes, but what do the experts say?
With exclusive commentary from Sheri Colberg, PhD.